Harbor Capital Advisors Inc. Sells 4,463 Shares of Encompass Health Co. (NYSE:EHC)

Harbor Capital Advisors Inc. lessened its position in Encompass Health Co. (NYSE:EHC - Free Report) by 6.1% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 68,164 shares of the company's stock after selling 4,463 shares during the period. Harbor Capital Advisors Inc. owned approximately 0.07% of Encompass Health worth $6,904,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in EHC. T. Rowe Price Investment Management Inc. acquired a new stake in Encompass Health in the fourth quarter valued at approximately $152,953,000. Norges Bank bought a new stake in shares of Encompass Health in the fourth quarter valued at $100,637,000. Raymond James Financial Inc. bought a new stake in shares of Encompass Health in the fourth quarter valued at $77,944,000. Farallon Capital Management LLC raised its stake in shares of Encompass Health by 15,266.7% in the fourth quarter. Farallon Capital Management LLC now owns 461,000 shares of the company's stock valued at $42,573,000 after buying an additional 458,000 shares during the period. Finally, AQR Capital Management LLC grew its position in shares of Encompass Health by 136.8% in the fourth quarter. AQR Capital Management LLC now owns 689,206 shares of the company's stock valued at $63,648,000 after purchasing an additional 398,154 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Encompass Health Trading Down 0.0%

Shares of NYSE EHC traded down $0.02 during midday trading on Wednesday, reaching $119.21. The company had a trading volume of 674,661 shares, compared to its average volume of 702,486. Encompass Health Co. has a one year low of $82.74 and a one year high of $123.13. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The firm's fifty day moving average price is $112.67 and its 200-day moving average price is $103.04. The stock has a market cap of $12.02 billion, a PE ratio of 26.73, a price-to-earnings-growth ratio of 2.31 and a beta of 0.89.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the previous year, the company posted $1.12 EPS. Encompass Health's revenue for the quarter was up 10.6% on a year-over-year basis. On average, equities research analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.57%. The ex-dividend date is Tuesday, July 1st. Encompass Health's payout ratio is 14.05%.

Analyst Upgrades and Downgrades

EHC has been the subject of several recent research reports. Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. UBS Group lifted their price target on Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a research report on Monday, April 28th. Barclays lifted their price target on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research report on Friday, April 25th. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price for the company in a research report on Thursday, June 5th. Finally, KeyCorp boosted their target price on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 27th. Eight analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $127.00.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, insider Elissa Joy Charbonneau sold 4,279 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the completion of the transaction, the insider now owns 11,958 shares in the company, valued at approximately $1,394,422.38. This represents a 26.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Mark J. Tarr sold 118,384 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the transaction, the chief executive officer now owns 527,070 shares of the company's stock, valued at approximately $64,054,817.10. This trade represents a 18.34% decrease in their position. The disclosure for this sale can be found here. Insiders sold 132,663 shares of company stock valued at $16,034,082 in the last 90 days. Insiders own 2.00% of the company's stock.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.